The increasing field of targeted treatment relies heavily on recombinant growth factor technology, and a thorough understanding of individual profiles is essential for refining experimental design and therapeutic efficacy. Specifically, examining the attributes of recombinant IL-1A, IL-1B, IL-2, and IL-3 highlights important differences in their mo